Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mather

Showing results (451-460 of 504) with videos related to

Pageof 51
Sort By:
Infectious Diseases of Poverty|December 14, 2018
Development of a data collection and management system in West Africa: challenges and sustainabilityJeffrey G Shaffer, Seydou O Doumbia, Daouda Ndiaye, et al.
Frontiers in Immunology|May 13, 2021
Islet Autoimmunity in Adults With Impaired Glucose Tolerance and Recently Diagnosed, Treatment Naïve Type 2 Diabetes in the Restoring Insulin SEcretion (RISE) StudyBarbara M Brooks-Worrell, Ashley H Tjaden, Sharon L Edelstein, et al.
Journal of the American College of Cardiology|August 20, 2011
S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytesHenriette Brinks, David Rohde, Mirko Voelkers, et al.
Nature Materials|May 18, 2010
Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imagingSung You Hong, Gerard Tobias, Khuloud T Al-Jamal, et al.
Molecular Metabolism|December 14, 2025
Long-acting GIPR agonist LY3537021 reduces body weight and fasting blood glucose in patients with T2D: Preclinical development and phase 1 randomized ascending dose studiesWilliam Roell, Jorge Alsina-Fernandez, Hongchang Qu, et al.
Basic Research in Cardiology|June 15, 2013
Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitusSteven P Moberly, Kieren J Mather, Zachary C Berwick, et al.
Molecular Pharmaceutics|July 4, 2014
PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)InS Roosenburg, P Laverman, L Joosten, et al.
Diabetes|November 4, 2015
Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program ParticipantsMarie-France Hivert, Costas A Christophi, Paul W Franks, et al.
Cell Metabolism|January 11, 2023
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonistOlivier Benichou, Tamer Coskun, Malgorzata D Gonciarz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 29, 2015
Selective inhibition of KCC2 leads to hyperexcitability and epileptiform discharges in hippocampal slices and in vivoSudhir Sivakumaran, Ross A Cardarelli, Jamie Maguire, et al.
Pageof 51

Showing results (451-460 of 504) with videos related to

Sort By:
Pageof 51
Infectious Diseases of Poverty|December 14, 2018
Development of a data collection and management system in West Africa: challenges and sustainabilityJeffrey G Shaffer, Seydou O Doumbia, Daouda Ndiaye, et al.
Frontiers in Immunology|May 13, 2021
Islet Autoimmunity in Adults With Impaired Glucose Tolerance and Recently Diagnosed, Treatment Naïve Type 2 Diabetes in the Restoring Insulin SEcretion (RISE) StudyBarbara M Brooks-Worrell, Ashley H Tjaden, Sharon L Edelstein, et al.
Journal of the American College of Cardiology|August 20, 2011
S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytesHenriette Brinks, David Rohde, Mirko Voelkers, et al.
Nature Materials|May 18, 2010
Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imagingSung You Hong, Gerard Tobias, Khuloud T Al-Jamal, et al.
Molecular Metabolism|December 14, 2025
Long-acting GIPR agonist LY3537021 reduces body weight and fasting blood glucose in patients with T2D: Preclinical development and phase 1 randomized ascending dose studiesWilliam Roell, Jorge Alsina-Fernandez, Hongchang Qu, et al.
Basic Research in Cardiology|June 15, 2013
Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitusSteven P Moberly, Kieren J Mather, Zachary C Berwick, et al.
Molecular Pharmaceutics|July 4, 2014
PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)InS Roosenburg, P Laverman, L Joosten, et al.
Diabetes|November 4, 2015
Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program ParticipantsMarie-France Hivert, Costas A Christophi, Paul W Franks, et al.
Cell Metabolism|January 11, 2023
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonistOlivier Benichou, Tamer Coskun, Malgorzata D Gonciarz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 29, 2015
Selective inhibition of KCC2 leads to hyperexcitability and epileptiform discharges in hippocampal slices and in vivoSudhir Sivakumaran, Ross A Cardarelli, Jamie Maguire, et al.
Pageof 51